Lynwood Capital Management »

Biorestorative Therapies shares owned by Lynwood Capital Management

Quarter-by-quarter ownership of Biorestorative Therapies (BRTX) shares owned by Lynwood Capital Management from 13F filings

Historical chart of Lynwood Capital Management investment in Biorestorative Therapies

Tip: Access up to 7 years of quarterly data

All positions including Biorestorative Therapies held by Lynwood Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biorestorative Therapies by Lynwood Capital Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $36k 20k 1.79

More positions owned by Lynwood Capital Management

Briacell Therapeutics Corp
Americas Gold And Silver Cor (USAS)
Vaneck Etf Trust Gold Miners Etf (GDX)
Altimmune Com New (ALT)
Immix Biopharma (IMMX)
Advanced Micro Devices (AMD)
Teck Resources CL B (TECK)
Petroleo Brasileiro Sa Petro Sponsored Adr (PBR)
Spire Global Com Cl A New (SPIR)
Sociedad Quimica Y Minera De Spon Adr Ser B (SQM)
Vermilion Energy (VET)
Lightspeed Commerce Sub Vtg Shs (LSPD)
Diamond Offshore Drilli (DO)
Mag Silver Corp
Transocean Registered Shs (RIG)

View all positions for Lynwood Capital Management

Top funds holding Biorestorative Therapies

Citadel Advisors
Vanguard Group
Geode Capital Management
Wealth Alliance
Intl Fcstone
Virtu Financial
State Street Corporation
Tower Research Capital
Advisor Group Holdings
Wells Fargo & Company
SBI Securities
TD Waterhouse Canada

View all funds holding Biorestorative Therapies